|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.19 USD | -1.30% |
|
+2.77% | -26.16% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.30% | +2.77% | +1.21% | -0.90% | -26.16% | +17.17% | +54.50% | +48.98% | +129.31% | 1.11B | |
| -0.32% | -1.72% | +12.38% | +14.65% | +5.09% | +37.83% | +148.79% | +405.26% | +1,432.15% | 1,007B | |
| -2.16% | +1.51% | +3.95% | -2.43% | +13.87% | +50.01% | +43.93% | +43.27% | +102.44% | 567B | |
| -2.70% | -0.66% | +5.32% | +0.87% | -3.02% | +15.97% | +63.07% | +91.31% | +266.87% | 392B | |
| -0.28% | +1.05% | +1.02% | +1.68% | -0.64% | +20.91% | +18.37% | -5.11% | +35.42% | 328B | |
| -0.22% | +1.18% | +2.20% | -1.37% | +9.29% | +24.29% | +31.97% | +40.62% | +62.63% | 277B | |
| +0.64% | -2.64% | -3.19% | -7.60% | -3.76% | +22.68% | +12.59% | +57.92% | +248.26% | 275B | |
| -0.46% | +5.58% | -0.51% | +14.60% | -12.51% | -42.87% | -48.44% | +9.63% | +68.17% | 196B | |
| -1.31% | +1.39% | +7.42% | -4.28% | +7.09% | +18.74% | +53.45% | +46.15% | +130.76% | 189B | |
| -1.03% | -2.97% | -4.07% | -14.27% | +1.27% | +13.02% | +57.34% | +82.55% | +49.69% | 154B | |
| -0.80% | +1.48% | +2.65% | -2.18% | +4.42% | +5.95% | -34.59% | -34.33% | -25.27% | 148B | |
| -1.56% | +1.21% | -1.33% | -4.81% | +4.26% | +13.05% | -13.04% | -16.58% | -22.50% | 115B | |
| +1.24% | +1.69% | +3.09% | -4.02% | -0.64% | -1.10% | +29.04% | +138.38% | +395.88% | 114B | |
| -0.07% | -2.01% | +1.55% | -1.33% | -8.74% | -12.10% | -21.09% | -15.15% | +11.39% | 105B | |
| +0.14% | +2.84% | +4.32% | -3.38% | +7.29% | +31.77% | +43.45% | +9.08% | +11.94% | 105B | |
| +1.28% | +1.99% | -4.59% | -17.48% | -8.73% | +0.82% | +77.30% | +66.62% | +533.96% | 76.33B | |
| -1.34% | +0.90% | -4.36% | -12.50% | +3.83% | +15.77% | +9.80% | +32.17% | +17.56% | 50.19B | |
| -1.26% | +4.22% | -11.32% | -13.12% | -19.62% | -11.15% | +2.02% | -33.39% | +235.24% | 46.79B | |
| -0.66% | +1.44% | -4.84% | -10.20% | -2.73% | +30.55% | -31.21% | -32.41% | -58.98% | 41.39B | |
| -2.71% | +1.29% | -1.75% | +17.92% | +7.95% | +98.29% | +344.46% | +210.51% | -35.69% | 39.23B | |
| Average | -0.01% | +0.88% | +0.46% | -2.51% | -1.11% | +17.48% | +42.09% | +57.27% | +179.46% | 211.43B | |
| Weighted average by Cap. | +0.09% | +0.19% | +4.11% | +1.78% | +2.82% | +23.53% | +57.96% | +127.13% | +434.73% |
- Stock Market
- Stocks
- COLL Stock
- Sector Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
